UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003648
Receipt number R000004409
Scientific Title A phase II study of allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies using intravenous busulfan and cyclophosphamide as conditioning regimen.
Date of disclosure of the study information 2010/06/15
Last modified on 2021/04/07 13:14:26

No. Disposal Last modified on Item of update
1 Insert 2010/05/21 10:13:15
2 Update 2010/05/27 14:06:14 Institute
Institute
Co-sponsor
Co-sponsor
3 Update 2010/05/27 14:09:44 Co-sponsor
Co-sponsor
4 Update 2010/06/18 17:02:54 Acronym
Acronym
5 Update 2010/06/22 13:30:20 Acronym
Acronym
6 Update 2010/06/22 13:44:23 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Address
Address
Last name of contact person
Last name of contact person
Organization
Organization
7 Update 2010/06/22 13:51:10 Last name of lead principal investigator
Organization
Organization
Organization
Division name
Division name
8 Update 2011/04/08 14:00:11 Email
Name of person sending information
Organization
Division name
Address
9 Update 2011/11/21 10:02:46 Address
Address
Post marketing survey by drug manufacture etc., specified by Japanese law.
10 Update 2012/05/21 09:53:02 Name of person sending information
Name of person sending information
11 Update 2013/05/07 13:57:15 Name of person sending information
Name of person sending information
12 Update 2013/05/07 13:57:36 Last follow-up date
13 Update 2013/10/22 17:09:38 Public title
14 Update 2014/05/21 09:32:56 TEL
Email
Address
Address
TEL
15 Update 2014/05/21 09:33:36 Last follow-up date
16 Update 2014/11/21 09:26:01 Recruitment status
17 Update 2015/08/29 09:34:19 Recruitment status
18 Update 2021/04/07 13:14:26 URL related to results and publications
Number of participants that the trial has enrolled